Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors.

Urologic oncology·2026
Same author

Robotic management of complex ileal conduit complications.

Journal of robotic surgery·2026
Same author

Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes.

Urologic oncology·2026
Same author

Globalization of clinical trials: participation, development and future directions.

Current opinion in urology·2026
Same author

Robotic retroperitoneal lymph node dissection: a stepwise technical guide.

Journal of robotic surgery·2026
Same author

Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study.

JCO global oncology·2026

Related Experiment Video

Updated: Jan 17, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Robotic-Assisted Retroperitoneal Lymph Node Dissection in a Challenging Post-Chemotherapy Case.

Willy Baccaglini1,2,3, Gabriel Chahade Sibanto Simões2, Julio Calderón2

  • 1Departamento de Urologia, Faculdade de Medicina do ABC, Santo André, SP, Brasil.

International Braz J Urol : Official Journal of the Brazilian Society of Urology
|September 15, 2025
PubMed
Summary

Robotic retroperitoneal lymph node dissection (RPLND) is feasible for large post-chemotherapy testicular cancer masses. This minimally invasive approach offers excellent outcomes and faster recovery in experienced centers.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.0K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

823

Related Experiment Videos

Last Updated: Jan 17, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.0K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

823

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Robotic retroperitoneal lymph node dissection (RPLND) offers a minimally invasive option for testicular germ cell tumors.
  • Post-chemotherapy residual masses present significant technical challenges for RPLND.

Purpose of the Study:

  • To present a case of robotic RPLND for a large post-chemotherapy residual mass in a testicular germ cell tumor patient.
  • To evaluate the feasibility and outcomes of robotic RPLND in a complex clinical scenario.

Main Methods:

  • A 23-year-old male with a residual interaortocaval mass post-chemotherapy underwent robotic RPLND.
  • The procedure involved a complete bilateral template dissection using four robotic ports.
  • En bloc tumor removal was achieved with meticulous dissection and advanced bipolar energy.

Main Results:

  • The bulky mass was successfully resected in 300 minutes with minimal blood loss (50 mL) and no intraoperative complications.
  • The patient experienced a rapid recovery, discharged on postoperative day one and resuming activities within two weeks.
  • At 6-month follow-up, the patient remained disease-free with normal tumor markers and no complications.

Conclusions:

  • Robotic RPLND is feasible for managing large post-chemotherapy residual masses in testicular cancer.
  • The robotic platform facilitates precise dissection in challenging cases, leading to favorable outcomes.
  • Centralized expertise and standardized techniques are crucial for optimal results in robotic RPLND.